Bupropion and cognitive-behavioral therapy for smoking cessation in women

Nicotine and Tobacco Research

Volumn 9, Issue 6, 2007, Pages 699-709

  Schmitz, Joy M ^a   Stotts, Angela L ^a   Mooney, Marc E ^a   DeLaune, Katherine A ^a   Moeller, F Gerard ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; PLACEBO;

ADULT; ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; DRUG EFFICACY; FACTORIAL DESIGN; FEMALE; FOLLOW UP; GROUP THERAPY; HEALTH CARE DELIVERY; HUMAN; LONGITUDINAL STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOTHERAPY; SMOKING CESSATION; SMOKING HABIT; SOCIAL SUPPORT; SUSTAINED RELEASE FORMULATION; TABLET FORMULATION; TOBACCO DEPENDENCE;

ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MIDDLE AGED; PATIENT COMPLIANCE; PSYCHOTHERAPY, GROUP; SMOKING CESSATION; TOBACCO USE DISORDER; TREATMENT OUTCOME; WOMEN'S HEALTH;

EID: 34250690361     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1080/14622200701365335     Document Type: Article

References (56)

1. Ahluwalia, J. S., Harris, K. J., Catley, D., Okuyemi, K. S. and Mayo, M. S. (2002) Sustained-release bupropion for smoking cessation in African Americans: A randomized controlled trial. The Journal of the American Medical Association, 288, pp. 497-499.
2. Beck, A., Ward, C., Mendelson, M., Mack, J. and Erbaugh, J. (1961) An inventory of measuring depression. Archives of General Psychiatry, 49, pp. 599-608.
3. Benowitz, N. L. (2002) Biochemical verification of tobacco use and cessation. Nicotine & Tobacco Research, 4, pp. 149-159.
4. Bjornson, W., Rand, C., Connett, J. E., Lindgren, P., Nides, M., Pope, F., Buist, A. S., Hoppe-Ryan, C. and O'Hara, P. (1995) Gender differences in smoking cessation after 3 years in the Lung Health Study. American Journal of Public Health, 85, pp. 223-230.
5. Borrelli, B., Papandonatos, G., Spring, B., Hitsman, B. and Niaura, R. (2004) Experimenter-defined quit dates for smoking cessation: Adherence improves outcomes for women but not for men. Addiction, 99, pp. 378-385.
6. Carroll, K. M. (1996) Relapse prevention as a psychosocial treatment: A review of controlled clinical trials. Experimental and Clinical Psychopharmacology, 4, pp. 46-54.
7. Collins, B. N., Wileyto, E. P., Patterson, F., Rukstalis, M., Audrain-McGovern, J., Kaufmann, V., Pinto, A., Hawk, L., Niaura, R., Epstein, L. H. and Lerman, C. (2004) Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling. Nicotine & Tobacco Research, 6, pp. 27-37.
8. Condiotte, M. M. and Lichtenstein, E. (1981) Self-efficacy and relapse in smoking cessation programs. Journal of Consulting and Clinical Psychology, 49, pp. 648-658.
9. Covey, L. S., Glassman, A. H., Stetner, F., Rivelli, S. and Stage, K. (2002) A randomized trial of sertraline as a cessation aid for smokers with a history of major depression. American Journal of Psychiatry, 159, pp. 1731-1737.
10. Etringer, B. D., Gregory, V. R. and Lando, H. A. (1984) Influence of group cohesion on the behavioral treatment of smoking. Journal of Consulting and Clinical Psychology, 52, pp. 1080-1086.
11. Evins, A. E., Cather, C., Deckersbach, T., Freudenreich, O., Culhane, M. A., Olm-Shipman, C. M., Henderson, D. C., Schoenfeld, D. A., Goff, D. C. and Rigotti, N. A. (2005) A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia. Journal of Clinical Psychopharmacology, 25, pp. 218-225.
12. Evins, A. E., Mays, V. K., Rigotti, N. A., Tisdale, T., Cather, C. and Goff, D. C. (2001) A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine & Tobacco Research, 3, pp. 397-403.
13. Ferry, L. H. and Burchette, R. J. (1994) Evaluation of bupropion versus placebo for treatment of nicotine dependence
14. Ferry, L. H., Robbins, A. S., Scariati, A. S., Masterson, A., Abbey, D. E., Raoul, J. and Burchette, J. L. (1992) Enhancement of smoking cessation using the antidepressant bupropion hydrochloride. Circulation, 86, p. 647.
15. Fiore, M. C., Bailey, W. C., Cohen, S. J., Dorfman, S. F., Goldstein, M. G., Gritz, E. R., Heyman, R. B., Holbrook, J., Jaen, C. R., Kottke, T. E., Lando, H. A., Mecklenbur, R., Mullen, P. D., Nett, L. M., Robinson, L., Stitzer, M., Tommasello, A. C., Villejo, L. and Wewers, M. E. (2000) Treating tobacco use and dependence. Clinical practice guideline, U.S. Department of Health and Human Services. Public Health Service, Rockville, MD
16. First, M. B., Spitzer, R. L., Gibbon, M. and Williams, J. B. (1995) Structured Clinical Interview for DSM-IV axis I Disorders-patient edition (SCID -I/P, Version 2.0), Biometric Research Department, New York
17. Gardner, W., Mulvey, E. P. and Shaw, E. C. (1995) Regression analyses of counts and rates: Poisson, overdispersed Poisson, and negative binomial models. Psychological Bulletin, 118, pp. 392-404.
18. Gonzales, D., Bjornson, W., Durcan, M. J., White, J. D., Johnston, J. A., Buist, A. S., Sachs, D. P. L., Rigotti, N. A., Niaura, R., Hays, J. T. and Hurt, R. D. (2002) Effects of gender on relapse prevention in smokers treated with bupropion SR. American Journal of Preventive Medicine, 22, pp. 234-239.
19. Gonzales, D. H., Nides, M. A., Ferry, L. H., Kustra, R. P., Jamerson, B. D., Segall, N., Herrero, L. A., Krishen, A., Sweeney, A., Buaron, K. and Metz, A. (2001) Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: A randomized placebo-controlled study. Clinical and Pharmacological Therapeutics, 69, pp. 438-444.
20. Hall, S. M., Delucchi, K. L., Velicer, W. F., Kahler, C. W., Ranger-Moore, J., Hedeker, D., Tsoh, J. Y. and Niaura, R. (2001) Statistical analysis of randomized trials in tobacco treatment: Longitudinal designs with dichotomous outcome. Nicotine & Tobacco Research, 3, pp. 193-202.
21. Hall, S. M., Humfleet, G. L., Reus, V. I., Muñoz, R. F., Hartz, D. T. and Maude-Griffin, R. (2004) Extended nortriptyline and psychological treatment for cigarette smoking. American Journal of Psychiatry, 161, pp. 2100-2107.
22. Hays, J. T., Hurt, R. D., Rigotti, N. A., Niaura, R., Gonzales, D., Durcan, M. J., Sachs, D. P., Wolter, T. D., Buist, A. S., Johnston, J. A. and White, J. D. (2001) Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation: A randomized, controlled trial. Annals of Internal Medicine, 135, pp. 423-433.
23. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C. and Fagerström, K. O. (1991) The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. British Journal of Addictions, 86, pp. 1119-1127.
24. Hedeker, D., Gibbons, R. D. and Flay, B. R. (1994) Random-effects regression models for clustered data with an example from smoking prevention research. Journal of Consulting and Clinical Psychology, 62, pp. 757-765.
25. Hertzberg, M. A., Moore, S. D., Feldman, M. E. and Beckham, J. C. (2001) A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder. Journal of Clinical Psychopharmacology, 21, pp. 94-98.
26. Herzog, T. A., Lazev, A. B., Irvin, J. E., Juliano, L. M., Greenbaum, P. E. and Brandon, T. H. (2002) Testing for group membership effects during and after treatment: The example of group therapy for smoking cessation. Behavior Therapy, 33, pp. 29-33.
27. Horwitz, R. I. and Horwitz, S. M. (1993) Adherence to treatment and health outcomes. Archives of Internal Medicine, 153, pp. 1863-1868.
28. Hughes, J. R. and Hatsukami, D. K. (1986) Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry, 43, pp. 289-294.
29. Hughes, J. R., Keely, J. P., Niaura, R. S., Ossip-Klein, D. J., Richmond, R. L. and Swan, G. E. (2003) Measures of abstinence in clinical trials: Issues and recommendations. Nicotine & Tobacco Research, 5, pp. 13-25.
30. Hurt, R. D., Krook, J. E., Croghan, I. T., Loprinzi, C. L., Sloan, J. A. and Novotny, P. J. (2003) Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking. Journal of Clinical Oncology, 21, pp. 914-920.
31. Hurt, R. D., Sachs, D. P., Glover, E. D., Offord, K. P., Johnston, J. A., Dale, L. C., Khayrallah, M. A., Schroeder, D. R., Glover, P. N., Sullivan, C. R., Croghan, I. T. and Sullivan, P. M. (1997) A comparison of sustained-release bupropion and placebo for smoking cessation. The New England Journal of Medicine, 337, pp. 1195-1202.
32. Irvine, J., Baker, B., Smith, J., Jandciu, S., Paquette, M., Cairns, J., Connolly, S., Roberts, R., Gent, M. and Dorian, P. (1999) Poor adherence to placebo or amiodarone therapy predicts mortality: Results from the CAMIAT study. Psychosomatic Medicine, 61, pp. 566-575.
33. Jackson, P. H., Stapleton, J. A., Russell, M. A. and Merriman, R. J. (1989) Nicotine gum use and outcome in a general practitioner intervention against smoking. Addictive Behaviors, 14, pp. 335-341.
34. Killen, J. D., Robinson, T. N., Ammerman, S., Hayward, C., Rogers, J., Stone, C., Samuels, D., Levin, S. K., Green, S. and Schatzberg, A. F. (2004) Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers. Journal of Consulting and Clinical Psychology, 72, pp. 729-735.
35. Littell, R. C., Milliken, G. A., Stroup, W. W. and Wolfinger, R. S. (1996) SAS system for mixed models, SAS Institute Inc, Cary, NC
36. Marcus, B. H., Lewis, B. A., King, T. K., Albrecht, A. E., Hogan, J., Bock, B., Parisi, A. F. and Abrams, D. B. (2003) Rationale, design, and baseline data for Commit to Quit II: An evaluation of the efficacy of moderate-intensity physical activity as an aid to smoking cessation in women. Preventive Medicine, 36, pp. 479-492.
37. Marlatt, G. A. and Gordon, J. R. (1985) Relapse prevention: Maintenance strategies in the treatment of addictive behaviors, Guilford, New York
38. Mooney, M. E., Sayre, S. L., Hokanson, P. S., Stotts, A. L. and Schmitz, J. M. (2006) Adding MEMS feedback to behavioral smoking cessation therapy increases compliance with bupropion. Addictive Behaviors
39. Perkins, K. A. (1996) Sex differences in nicotine versus non-nicotine reinforcement as determinants of tobacco smoking. Experimental and Clinical Psychopharmacology, 4, pp. 166-177.
40. Perkins, K. A. (2001) Smoking cessation in women. Special considerations. CNS Drugs, 15, pp. 391-411.
41. Physicians' Desk Reference (2006)Thomson, Montvale, NJ
42. Piper, M. E., Fox, B. J., Welsch, S. K., Fiore, M. C. and Baker, T. B. (2001) Gender and racial/ethnic differences in tobacco-dependence treatment: A commentary and research recommendations. Nicotine & Tobacco Research, 3, pp. 291-297.
43. Ponciano, G., Morales, A. and Rivero, O. (2003) Behavioral intervention increased efficacy of bupropion in a group of Mexican heavy smokers
44. Reynoso, J., Susabda, A. and Cepeda-Benito, A. (2005) Gender differences in smoking cessation. Journal of Psychopathological Behavior, 27, pp. 227-234.
45. Scharf, D. and Shiffman, S. (2004) Are there gender differences in smoking cessation, with and without bupropion? Pooled- and meta-analyses of clinical trials of bupropion SR. Addiction, 99, pp. 1462-1469.
46. Schmitz, J. M., Spiga, R., Rhoades, H. M., Fuentes, F. and Grabowski, J. (1999) Smoking cessation in women with cardiac risk: A comparative study of two theoretically based therapies. Nicotine & Tobacco Research, 1, pp. 87-94.
47. Simon, J. A., Duncan, C., Carmody, T. P. and Hudes, E. S. (2004) Bupropion for smoking cessation: A randomized trial. Archives of Internal Medicine, 164, pp. 1797-1803.
48. Stout, R. L., Wirtz, P. W., Carbonari, J. P. and Boca, F. K. Del (1994) Ensuring balanced distribution of prognostic factors in treatment outcome research. Journal of Studies on Alcohol, 12, pp. 70-75.
49. Swan, G. E., Jack, L. M., Curry, S., Chorost, M., Javitz, H., McAfee, T. and Dacey, S. (2003) Bupropion SR and counseling for smoking cessation in actual practice: Predictors of outcome. Nicotine & Tobacco Research, 5, pp. 911-921.
50. Swan, G. E., Javitz, H. S., Jack, L. M., Curry, S. J. and McAfee, T. (2004) Heterogeneity in 12-month outcome among female and male smokers. Addiction, 99, pp. 237-250.
51. Swan, G. E., McAfee, T., Curry, S. J., Jack, L. M., Javitz, H., Dacey, S. and Bergman, K. (2003) Effectiveness of bupropion sustained release for smoking cessation in a health care setting: A randomized trial. Archives of Internal Medicine, 163, pp. 2337-2344.
52. Tashkin, D. P., Kanner, R., Bailey, W., Buist, S., Anderson, P. J. and Nides, M. A. (2001) Smoking cessation in patients with chronic obstructive pulmonary disease: A double-blind, placebo-controlled, randomised trial. Lancet, 357, pp. 1571-1575.
53. Tiffany, S. T. and Drobes, D. J. (1991) The development and initial validation of a questionnaire on smoking urges. British Journal of Addiction, 86, pp. 1467-1476.
54. Tonstad, S., Farsang, C., Klaene, G., Lewis, K., Manolis, A., Perruchoud, A. P., Silagy, C., van, I. Spiegel P., Astbury, C., Hider, A. and Sweet, R. (2003) Bupropion SR for smoking cessation in smokers with cardiovascular disease: A multicentre, randomised study. European Heart Journal, 24, pp. 946-955.
55. Waltz, J., Addis, M. E., Koerner, K. and Jacobson, N. S. (1993) Testing the integrity of a psychotherapy protocol: Assessment of adherence and competence. Journal of Consulting and Clinical Psychology, 61, pp. 620-630.
56. Weiner, E., Ball, M. P., Summerfelt, A., Gold, J. and Buchanan, R. W. (2001) Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia. American Journal of Psychiatry, 158, pp. 635-637.